moderna spikevax - Search News

News

Moderna, COVID-19 and Spikevax

Medical Dialogues · 49m

Moderna Spikevax gets full USFDA nod for kids 6 months through 11 years at increased COVID risk

Cambridge: Moderna has received approval from the U.S. Food and Drug Administration (FDA) for the supplemental Biologics License Application (sBLA) for Spikevax, the Company's COVID-19 vaccine,

Reuters on MSN · 2d

Moderna gets full US approval for COVID shot in at-risk children 6 months and older

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday.

The Sacramento Bee · 2d

Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease

Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease

FDA grants full approval to Moderna’s Covid vaccine for children but limits eligibility

Moderna’s Covid vaccine for children has been given full FDA approval, making it the first such shot for kids in the U.S.

Zacks.com on MSN1d

MRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric Patients

Moderna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months to ...

2don MSN

Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win

Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results